Cargando…
HIV-1 protease inhibition potential of functionalized polyoxometalates
Polyoxometalates (POMs) are interesting biomedical agents due to their versatile anticancer and antiviral properties, such as remarkable anti-HIV activity. Although POMs are tunable and easily accessible inorganic drug prototypes in principle, their full potential can only be tapped by enhancing the...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126215/ https://www.ncbi.nlm.nih.gov/pubmed/21256010 http://dx.doi.org/10.1016/j.bmcl.2010.12.103 |
_version_ | 1783516100248469504 |
---|---|
author | Flütsch, Andreas Schroeder, Thilo Grütter, Markus G. Patzke, Greta R. |
author_facet | Flütsch, Andreas Schroeder, Thilo Grütter, Markus G. Patzke, Greta R. |
author_sort | Flütsch, Andreas |
collection | PubMed |
description | Polyoxometalates (POMs) are interesting biomedical agents due to their versatile anticancer and antiviral properties, such as remarkable anti-HIV activity. Although POMs are tunable and easily accessible inorganic drug prototypes in principle, their full potential can only be tapped by enhancing their biocompatibility, for example, through organic functionalization. We have therefore investigated the HIV-1 protease inhibition potential of functionalized Keggin- and Dawson-type POMs with organic side chains. Their inhibitory performance was furthermore compared to other POM types, and the buffer dependence of the results is discussed. In addition, chemical shift mapping NMR experiments were performed to exclude POM–substrate interactions. Whereas the introduction of organic side chains into POMs is a promising approach in principle, the influence of secondary effects on the reaction system also merits detailed investigation. |
format | Online Article Text |
id | pubmed-7126215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71262152020-04-08 HIV-1 protease inhibition potential of functionalized polyoxometalates Flütsch, Andreas Schroeder, Thilo Grütter, Markus G. Patzke, Greta R. Bioorg Med Chem Lett Article Polyoxometalates (POMs) are interesting biomedical agents due to their versatile anticancer and antiviral properties, such as remarkable anti-HIV activity. Although POMs are tunable and easily accessible inorganic drug prototypes in principle, their full potential can only be tapped by enhancing their biocompatibility, for example, through organic functionalization. We have therefore investigated the HIV-1 protease inhibition potential of functionalized Keggin- and Dawson-type POMs with organic side chains. Their inhibitory performance was furthermore compared to other POM types, and the buffer dependence of the results is discussed. In addition, chemical shift mapping NMR experiments were performed to exclude POM–substrate interactions. Whereas the introduction of organic side chains into POMs is a promising approach in principle, the influence of secondary effects on the reaction system also merits detailed investigation. Elsevier Ltd. 2011-02-15 2010-12-25 /pmc/articles/PMC7126215/ /pubmed/21256010 http://dx.doi.org/10.1016/j.bmcl.2010.12.103 Text en Copyright © 2010 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Flütsch, Andreas Schroeder, Thilo Grütter, Markus G. Patzke, Greta R. HIV-1 protease inhibition potential of functionalized polyoxometalates |
title | HIV-1 protease inhibition potential of functionalized polyoxometalates |
title_full | HIV-1 protease inhibition potential of functionalized polyoxometalates |
title_fullStr | HIV-1 protease inhibition potential of functionalized polyoxometalates |
title_full_unstemmed | HIV-1 protease inhibition potential of functionalized polyoxometalates |
title_short | HIV-1 protease inhibition potential of functionalized polyoxometalates |
title_sort | hiv-1 protease inhibition potential of functionalized polyoxometalates |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126215/ https://www.ncbi.nlm.nih.gov/pubmed/21256010 http://dx.doi.org/10.1016/j.bmcl.2010.12.103 |
work_keys_str_mv | AT flutschandreas hiv1proteaseinhibitionpotentialoffunctionalizedpolyoxometalates AT schroederthilo hiv1proteaseinhibitionpotentialoffunctionalizedpolyoxometalates AT gruttermarkusg hiv1proteaseinhibitionpotentialoffunctionalizedpolyoxometalates AT patzkegretar hiv1proteaseinhibitionpotentialoffunctionalizedpolyoxometalates |